CMS advises SYNLAB on acquisition of WolfartKlinik

Stuttgart – The SYNLAB Group has acquired the WolfartKlinik hospital in Gräfelfing near Munich from the Wolfart family. The transaction was agreed in February 2023 and has now been successfully completed, following receipt of the approvals required under merger control rules and hospital regulations. The WolfartKlinik has 100+ beds and forms part of the state-level hospitals plan. Details of the transaction were not disclosed.

A CMS team headed by Dr Christoph Lächler advised SYNLAB on all legal aspects of the complex acquisition process and on the restructuring carried out between signing and closing. The SYNLAB Group is a longstanding CMS client and regularly relies on the expertise of the Corporate/M&A team led by Dr Christoph Lächler.

The SYNLAB Group is one of Europe’s largest providers of clinical laboratory and medical diagnostic services, based on revenue and number of tests. SYNLAB offers a full range of innovative and reliable medical diagnostics for patients, general practitioners, hospitals and the pharmaceutical industry.

CMS Germany

Dr Christoph Lächler, Lead Partner
Dr Georg Lauster, Principal Counsel
Katharina Mareike Franitza, Counsel
Birgit Schlemmer, Senior Associate
Andreas Kazmaier, Associate, all Corporate/M&A
Dr Harald Kahlenberg, Partner, Antitrust
Dr Roland Wiring, Partner
Siham Hidar, Associate, both Regulatory
Dr Michael Kraus, Partner
Dr Arne Schmieke, Senior Associate, both Data Protection
Dr Julia Dönch, Partner, IP
Dr Stefan Voß, Partner
Lukas Potstada, Counsel, both Real Estate & Public
Dr Sören Langner, Partner
Dr Daniel Ludwig, Partner
Annika Vanessa Kemna, Counsel
Neil Yeats, Counsel
Dr Christian Schneiders, Senior Associate, all Employment
Dr Daniel Kaiser, Partner, Compliance

Inhouse SYNLAB Legal/M&A Team (Munich)

Dr Fabian Walla, Group General Counsel
Dr Peter Macheiner, Head of Legal M&A and Procurement

Press Contact
presse@cms-hs.com